专家：小儿白血病治疗全国方案亟须调整 experts：The children leukemia treatment plan it is urgent to adjust

　　在广医一院日前举行的白血病儿童联谊会上，我国著名儿童血液病专家、广医附属一院儿科教授冯梓梁指出，我国每年新增小儿白血病的发生率为十万分之三到五，治愈率最高可达80%左右，然而，我国小儿白血病治疗的国家方案仍然存在着低危患儿治疗过度、高危患儿治疗不足的问题，导致约20%的患儿死亡。

A court in GuangYi held a leukemia children on the association，The famous children's blood disease experts、GuangYi attached a courtyard department of pediatrics professor FengZiLiang pointed out，Every year in our country new children leukemia incidence of three over one hundred thousand to five，The highest rate can reach 80%，however，Our country children leukemia treatment still exist national plan low-risk patients excessive treatment、Children at risk to the problem of shortage of treatment，About 20% of the children to death。

误区一：患白血病等于被宣判死刑 Error a：Suffer from leukaemia is equal to be sentenced to death

　　冯梓梁说，目前，我国每年的白血病新增病例的发生率是十万分之三到五。“很多家庭只要孩子得了白血病，就觉得治愈无望。但事实上，小儿白血病是可以治愈的，而且治疗率很高。在一所对治疗白血病有经验的医院，小儿白血病治愈率可达80%，甚至更高。”

FengZiLiang said，At present，Every year in our country of the new cases leukemia incidence is three over one hundred thousand to five。“Many families as long as children with leukemia，Feel cure hopelessness。But in fact，Children leukaemia can be cured，And the therapy is very high。In a in the treatment of leukemia have experience of hospital，Children leukaemia cure rate can amount to 80%，Even higher。”

误区二：都要做骨髓移植 Error two：Have to do a bone marrow transplant

　　“很多人一听白血病，都自然而然想到要做骨髓移植。”冯梓梁说，“小儿白血病骨髓移植的治疗方法在医学界已基本被否定。”冯梓梁说，该治疗方法，风险很大，复发率也很高，而且费用高昂。“动辄四五十万元，最高的甚至需要100万，而成功率不到1/3。”他说，现在，治疗小儿白血病的专家已经取得共识，小儿白血病一般不需做骨髓移植，通过化疗，也就是西药治疗就可以治好，“包括18岁以内的青少年患者”。

“A lot of people to leukemia，All naturally want to do a bone marrow transplant。”FengZiLiang said，“Children leukaemia marrow transplant treatment method in the medical profession has basically be negative。”FengZiLiang said，The treatment，The risk is very big，The recurrence rate is also very high，And the high cost of。“Frequently forty or fifty ten thousand yuan，The highest even need 1 million，And the success rate less than one-third。”He said，now，To treat in the young child leukemia experts have come to an agreement，Children leukaemia generally do not need to do a bone marrow transplant，Through the chemotherapy，Is western medicine therapy can cure，“Including 18 patients within the teenagers”。

“经济”方案：治愈率90%费用平均只需7万 “economic”scheme：Cure rate 90% average cost only 70000

　　冯梓梁介绍，“关于白血病的治疗，国家已经制定了全国方案。”但是，经过他和他的团队多年的实践，他们发现现有全国方案标准存在着对低危患儿过度治疗和高危患儿治疗不足的问题。“按照目前的全国方案标准对低危患儿的治疗，下药太重。”一般低危患儿的治疗费用需要10万~20万元，使得很多家庭放弃对孩子的治疗。另一方面，对低危患儿下药太重，会带来很大的副作用，让患儿死于因化疗导致的并发症。“这个比例约在10%左右。”

FengZiLiang introduced，“About the treatment of leukemia，Countries have established the national scheme。”but，After he and his team many years of practice，They found that the existing national standard scheme exist for low-risk patients excessive treatment and high-risk patients to the problem of shortage of treatment。“According to the present national standard scheme for the treatment of children with low risk，The remedy to the case is too heavy。”General low-risk patients of the cost of treatment need 100000 ~ 200000 yuan，Makes many families give up on the treatment of children。On the other hand，For low-risk patients the remedy to the case is too heavy，Will bring a lot of side effects，Let children die through chemotherapy cause complications。“The proportion about 10%。”

　　“对于低危患儿，适宜采用‘经济方案’。”冯梓梁说，“从20多个病例来看，成功率达90%，而费用只是要全国方案标准治疗费用的一半左右，三年的治疗期平均只需7万元左右。”

“For low-risk patients，Adopt, is the‘Economic scheme’。”FengZiLiang said，“From more than 20 cases to see，Success rate was 90%，And the costs just to the national scheme of the standard treatment cost about half，Three years of treatment period average only 70000 yuan。”

治疗不足：10%高危患儿因用药过低导致复发而死 Therapy in：10% of patients at risk for medication too low lead to recurrence and death

　　冯梓梁说，目前的白血病治疗全国方案中还存在着对高危患儿治疗不足的问题，“也就是说，药量是不够的”。“对高危患儿的药量不足，就会容易导致复发，一复发就意味着治疗失败，也就是意味着病人死亡。”他说，白血病不管程度如何，只要一复发，就很难治愈。“大约有10%的高危患儿因用药过低导致复发而死亡。”

FengZiLiang said，The leukemia treatment the national plan for high risk patients still exist the problem of shortage of treatment，“That is，The drug is not enough”。“For high risk infants insufficient quantity，Will be easy to cause the recurrence，A recurrence means treatment failure，Also means patients died。”He said，Leukemia no matter how degree，As long as a recurrence，It is difficult to cure。“About 10% of patients at risk for medicine too low lead to recurrence and death。”

　　冯梓梁说，正是基于这种考虑，针对高危白血病患儿，广医一院在全国方案的基础上，制定了“超高危”方案。他说，“采用‘超高危’治疗方案，加强治疗，可明显减少高危患儿的复发率。”

FengZiLiang said，Based on this consideration，According to high-risk leukemia children，GuangYi a court in the national scheme based on the，Formulated the“Ultra high risk”scheme。He said，“the‘Ultra high risk’treatment，Strengthening treatment，Can obviously reduce the recurrence rate of high risk patients。”

　　“无论是为了防止因治疗不足而导致复发，还是为了防止因过度治疗而导致化疗并发症，白血病治疗全国方案都应该重新作出调整。”冯梓梁呼吁。(文/记者黄蓉芳 通讯员余健新 图/记者乔军伟)

“Whether in order to prevent deficiency by treatment and cause relapse，In order to prevent or because of excessive treatment and lead to chemotherapy complication，Leukemia treatment the national scheme should be to make adjustment。”FengZiLiang called for。(Wen/reporter HuangRongFang correspondent YuJian new diagram/reporter QiaoJunWei)